Thursday 24 September 2026 · Edition of the day

Current editionPast editions →

The Skeptic's Daily

The day's biggest stories, taken apart. For each one: what is actually established, what is only asserted, the questions worth asking — and a plausibility score for the central claim, given everything currently known.

Stories
3
Average plausibility
74%
How to read the score
It rates how well the core claim is evidenced — not how important the story is, nor whether it is good or bad news.
RegionAllGlobalAfricaNorth AmericaSouth AmericaAsia-PacificEuropeMiddle East
TopicAllPoliticsConflict & SecurityBusinessScienceHealth
01BusinessNorth America

Trump and Xi meet in Washington to discuss extending the trade truce

The summit centers on extending a fragile tariff truce rather than delivering major breakthroughs, analysts say.

Chinese President Xi Jinping traveled to Washington for a summit with President Trump beginning 24 September 2026, their second meeting this year. Both sides have signalled they expect to extend the existing 'Busan' trade truce, due to expire in November, rather than announce sweeping new agreements. Discussions reportedly cover tariff carve-outs on up to $30 billion of goods, an AI dialogue and rare-earth export controls.

What holds up

  • ✓The summit schedule, including a state arrival ceremony, was confirmed by CBS News and the White House.
  • ✓Both governments have publicly said they are discussing extending the truce beyond November.

What doesn't yet

  • ?The scope of any tariff carve-outs (up to $30 billion) is preliminary and unconfirmed.
  • ?Claims of 'very successful' AI and trade talks come from US officials and are not independently verified.
  • ?Whether Taiwan or human rights will feature is speculation, not a confirmed agenda item.

Ask before you share

  • →Will the extension include verifiable commitments or remain symbolic?
  • →How will unresolved disputes over semiconductors and rare earths affect implementation?
  • →Could domestic politics in either country derail agreed terms after the summit?

Sources & original reporting

  1. [1]CBS News · Accessed 24 Sept 2026 · cbsnews.com
  2. [2]Reuters · Published 21 Sept 2026 · reuters.com
02HealthNorth America

Multi-cancer blood test boosts early detection 6.5-fold in a large study

PATHFINDER 2 results, published in Nature Medicine, support GRAIL's Galleri test ahead of an FDA advisory review.

Oregon Health & Science University researchers published PATHFINDER 2 results on 22 September 2026 showing GRAIL's Galleri test substantially increased cancer detection when added to standard screening. The findings appeared in Nature Medicine and were due to be presented to an FDA advisory committee. The test looks for signals of more than 50 cancer types in cell-free DNA.

What holds up

  • ✓Publication in Nature Medicine and the lead author are confirmed by OHSU.
  • ✓An FDA advisory committee review was scheduled after the study's release.

What doesn't yet

  • ?The '6.5-fold' figure is the study's own result and has not yet been assessed by regulators.
  • ?Performance in more diverse, real-world populations is unresolved.
  • ?GRAIL, the manufacturer, has a commercial interest in favorable results.

Ask before you share

  • →Will the FDA panel endorse approval?
  • →How will the test perform in groups with different risk profiles?
  • →What will it cost, and who will be able to access it?

Sources & original reporting

  1. [1]OHSU News · Published 22 Sept 2026 · news.ohsu.edu
03ScienceNorth America

Bird flu strain circulated undetected for months in North America, study finds

A surveillance gap let the D1.1 H5N1 variant spread unnoticed before its first confirmed detection.

A study led by Arizona State University's Matthew Scotch, with the Arizona Game and Fish Department, compared Arizona H5N1 D1.1 sequences with thousands of public samples. It concluded the lineage likely began expanding around summer 2024, months before its first recognized US detection. D1.1 has infected humans, including a fatal case in Louisiana in early 2025.

What holds up

  • ✓The study was carried out by ASU with the state wildlife department.
  • ✓D1.1 is a variant of the H5N1 clade driving the global outbreak.

What doesn't yet

  • ?The start date and origin of hidden spread are inferred from genetic modeling.
  • ?Whether this reflects an ongoing national surveillance failure is the authors' assertion.

Ask before you share

  • →How much of the wild bird population goes unsampled?
  • →What surveillance changes are planned before the next migration?
  • →What does this imply about current risk to humans?

Sources & original reporting

  1. [1]ASU News · Published 23 Sept 2026 · news.asu.edu